Associate Professor Nicole Kiss is an advanced APD with more than 20 years’ experience in cancer nutrition including clinical, research and health service management positions. Nicole is a Victorian Cancer Agency Clinical Research Fellow and co-lead of the Exercise and Nutrition for Cancer research group in the Institute for Physical Activity and Nutrition at Deakin University, Australia. Nicole’s research interests include interventions to optimize nutritional and functional outcomes during and after cancer therapy with a particular focus on body composition.

Dr Ashlee Mulimba, is a Chartered Health Psychologist with Healthy Dialogues. Ashlee has a special interest in behaviour change and behavioural science approaches to improving the health and wellbeing of individuals, communities and populations. Ashlee has been training the cancer workforce in Motivational Interviewing for over 15 years.

Jacqui is the Clinical Lead of the Speech Pathology team at Peter Mac in Melbourne, Australia. She has worked as a speech pathologist with a special interest in oncology for over 20 years and she now leads the busy clinical service at Peter Mac, with a team of 6 speech pathologists across two sites. Jacqui completed her PhD in 2009 and since this time has continued to conduct clinical research in communication and swallowing outcomes after cancer treatment, with a specific focus on head & neck and lung cancers. Jacqui is a regular invited lecturer at the University of Melbourne and La Trobe University on various topics in swallowing disorders, head and neck cancer and tracheostomy management.

Professor of Psychiatric & Mental Health Nursing, The ex- Dean Faculty of Nursing, Suez Canal University, Ismailia. Egypt. Now the Vice Dean, Post- graduate and Research Affairs, also the Head of Psychiatric and mental health nursing department. Visiting Scientist, Queen’s University School of Nursing, Kingston, ON Canada. A consultant in Nursing Education for Maastricht University, The contact person & member of the Tuning project (TEMPUS) "Tuning Middle East and North Africa". Active Membership of Psycho‐Oncology Society . Reviewer of many international & national Journals for example in Archives of Psychiatric Nursing Journal the editor the faculty of nursing scientific journal. My research interest in oncology area, community & Psychiatry mental health Nursing, human sexuality & Psych-Oncology Nursing.

Dr. Kidane is a Thoracic Surgeon with a special interest in minimally invasive and endoscopic approaches to benign and malignant thoracic/foregut disease. He completed his MD at the University of Toronto and his General Surgery Residency at Western University. He then completed Thoracic Surgery Residency at the University of Toronto. During this time, he benefited from the mentorship of global leaders in the fields of Thoracic Oncology (Dr Gail Darling) and Interventional Pulmonary Endoscopy (Dr Kazuhiro Yasufuku). He had the privilege of pursuing further training in Interventional Endoscopy at McGill with Dr Lorenzo Ferri and at the CHUM (Centre hospitalier de l'Université de Montréal) with Dr Moishe Liberman.
Dr. Kidane joined the Department of Surgery at the University of Manitoba in 2016. Since that time, he has established the Endoscopic Submucosal Resection program in Manitoba for incision-less treatment of esophageal cancer. He established the Non-Intubated VATS (Video-Assisted Thoracic Surgery) program in Manitoba, which has increased access to this modality for the management of high-risk thoracic patients as well as patients with malignant pleural effusions. All of these treatments are now being offered as outpatient therapy in the Wilf Tailleu Thoracic Endoscopy Clinic. Dr Kidane has a research interest in peri-operative care specifically in the thoracic surgery sphere but also in all surgical disciplines. His major interest is in lung protective ventilation during thoracic surgery as well as peri-operative practice variation and quality improvement. He also has a research interest in health services and outcomes research as it relates to esophageal and lung cancer. A major focus of his esophageal cancer research is in health-related quality of life. Esophageal cancer is a devastating illness with historically poor survival; furthermore, the treatment of esophageal cancer can also be difficult and cause significant reductions in the quality of life of patients with esophageal cancer. Dr Kidane’s program of research in esophageal cancer brings together elements of surgical quality, patient quality of life, oncologic outcomes and health resource utilization with the ultimate goal of identifying the right treatment for the right patient at the right time.

Matthias Guckenberger, MD, is Chairman of the Department for Radiation Oncology, University Hospital Zurich (USZ), and Professor at the University of Zurich (UZH). Integration of advanced imaging and radiotherapy into multimodality treatment of lung cancer has been a major research focus, especially stereotactic body radiotherapy (SBRT) for early stage NSCLC and oligo-metastatic disease. Safety and efficacy was evaluated in prospective clinical trials, in large multi-institutional and national patterns of care analyses. Mathematical and imaging-based modeling of tumor and normal tissue response to radiotherapy has been another focus. Overall, research has been published in >300 peer-reviewed articles.

Hisashi Saji is an internationally known Thoracic Surgeon with special expertise in minimal invasive, radical surgery and surgical oncology. He is currently Professor of Chest Surgery at St. Marianna University School of Medicine. He is also the principle investigator and coordinator of several pivotal clinical trials conducted by Lung Cancer Surgical Study Group in Japan Clinical Oncology Group. He graduated from Gifu University School of Medicine, Gifu, Japan in 1995. He trained as an intern in the International Medical Center of Japan and as a general surgery resident in Tokyo Metropolitan Komagome Hospital. Then, he pursued his Thoracic Surgery Training and research work regarding to cytokine mechanism in lung cancer tissues at Tokyo Medical University and have given PhD degree by this university. Since 2003, he has studied dendritic related tumor immunotherapy as a postdoctoral researcher in Prof. Engleman's lab at Department of Pathology, Stanford University School of Medicine for 2.5 years. He was appointed to the current position in 2019. Dr. Saji has more than 100 peer reviewed publications and book chapters. Over the recent years, he has lectured through a variety of topics related to thoracic surgical oncology and clinical studies. He has been a young leader and has several board certification in the field of thoracic surgery in Japan.

Dr. Mary Beth Beasley is a Professor of Pathology and Head of Thoracic Pathology at the Icahn School of Medicine at Mount Sinai in New York City. Dr. Beasley received her medical degree from Tulane University and completed her AP/CP training at Duke University and Tulane University. She subsequently was a fellow and staff pathologist at the Armed Forces Institute of Pathology in the division of Pulmonary and Mediastinal Pathology. Dr. Beasley serves of numerous national and international panels including the IASLC pathology panel, US and Canadian Mesothelioma Panel, International Mesothelioma Interest Group and is a member of the Fleischner Society. Dr. Beasley is also actively involved in the CAP lung cancer biomarkers committee, is an associate editor of Archives of Pathology and Laboratory Medicine and is a past chair of the CAP surgical pathology committee and member of the Council of Scientific Affairs. Dr. Beasley has served in multiple leadership roles in the Pulmonary Pathology Society since 2002 and is currently immediate past-President. Dr. Beasley has published over 150 peer reviewed articles and book chapters on various aspects of pulmonary pathology.

Vivek:
- is a Patient Advocate for Lung Cancer, Cancer Research, Clinical Trials and Timely Access to Latest Treatment in India.
- was caregiver & spouse of “Kusum Malik Tomar” a patient of stage 4 Lung Cancer (never-smoker) metastatic to brain, bones & others, who survived 7 long years with Hope, Courage, Research Medicines & Clinical Trials.
- has co-founded India’s 1st Oncogene-Focused Patient support group ‘ALK Positive India’ and also co-founded "Rise To Survive Cancer" an initiative for patient advocacy for Lung Cancer, Cancer Research, Clinical Trials and Timely Access to Latest Treatment in India.
- member of advisory board for cancer research initiative and faculty for cancer awareness programs for Government of India, research centres and many non-profits
- successfully led campaigns to bring many latest cancer medicines in India for patients access, in record time.
- key note speaker and panellist at many national and international conferences and seminars.
- member of IASLC and National Cancer Grid India
- IASLC WCLC 2018 Education Award Winner
- Vivek & Kusum’s story & advocacy work has featured in many national and international media including ‘The Week’, ‘The Hindu’, ‘Zee news’, ‘NDTV’, ‘Big FM’, ‘Josh Talks’, ‘Bloomberg’, ‘Aljazeera’ etc. and also part of a book on inspirational stories called "God is not fair?"